SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-16-001292
Filing Date
2016-11-14
Accepted
2016-11-14 17:29:14
Documents
57
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q appy_10q-093016.htm 10-Q 510265
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 8656
3 EXHIBIT 31.2 ex31x2.htm EX-31.1 9290
4 EXHIBIT 32.1 ex32.htm EX-32.1 6682
  Complete submission text file 0001079973-16-001292.txt   3269781

Data Files

Seq Description Document Type Size
5 appy-20160930.xml EX-101.INS 532597
6 appy-20160930.xsd EX-101.SCH 33672
7 appy-20160930_cal.xml EX-101.CAL 55952
8 appy-20160930_def.xml EX-101.DEF 141233
9 appy-20160930_lab.xml EX-101.LAB 312153
10 appy-20160930_pre.xml EX-101.PRE 239990
Mailing Address 1775 38TH STREET BOULDER CO 80301
Business Address 1775 38TH STREET BOULDER CO 80301 303-545-5550
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 161996134
SIC: 2835 In Vitro & In Vivo Diagnostic Substances